Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: A 31-phosphorus magnetic resonance spectroscopy study at 4T

Bipolar Disorders

Volumn 12, Issue 8, 2010, Pages 825-833

  Agarwal, Nivedita ^a,b,c   Sung, Young Hoon ^a   Jensen, J Eric ^c   daCunha, Grace ^c   Harper, David ^c   Olson, David ^c   Renshaw, Perry F ^a  

^a UNIVERSITY OF UTAH   (United States)

^b SANTA CHIARA HOSPITAL   (Italy)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Bipolar disorder; Epilepsy; Magnetic resonance spectroscopy; Phospholipids; Uridine

Indexed keywords

GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; MEMBRANE PHOSPHOLIPID; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; URIDINE;

ADULT; ARTICLE; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; METABOLITE; NEUROIMAGING; NORMAL HUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; BRAIN; CYTIDINE DIPHOSPHATE CHOLINE; ETHANOLAMINES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; PHOSPHORUS ISOTOPES; PHOSPHORYLCHOLINE; TIME FACTORS; URIDINE;

EID: 78650552248     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00884.x     Document Type: Article

References (42)

1. Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 2000; 107: 1027-1063.
2. Kent C. CTP:phosphocholine cytidylyltransferase. Biochim Biophys Acta 1997; 1348: 79-90.
3. Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res 2008; 49: 1377-1387.
4. Eyster KM. The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist. Adv Physiol Educ 2007; 31: 5-16.
5. Vance JE, Vance DE. Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol 2004; 82: 113-128.
6. Poccia D, Larijani B. Phosphatidylinositol metabolism and membrane fusion. Biochem J 2009; 418: 233-246.
7. Gohil VM, Greenberg ML. Mitochondrial membrane biogenesis: phospholipids and proteins go hand in hand. J Cell Biol 2009; 184: 469-472.
8. Exton JH. Cell signalling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases. Eur J Biochem 1997; 243: 10-20.
9. McMaster CR. Lipid metabolism and vesicle trafficking: more than just greasing the transport machinery. Biochem Cell Biol 2001; 79: 681-692.
10. Araki W, Wurtman RJ. How is membrane phospholipid biosynthesis controlled in neural tissues?. J Neurosci Res 1998; 51: 667-674.
11. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 1956; 222: 193-214.
12. Lecca D, Ceruti S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem Pharmacol 2008; 75: 1869-1881.
13. Savci V, Wurtman RJ. Effect of cytidine on membrane phospholipid synthesis in rat striatal slices. J Neurochem 1995; 64: 378-384.
14. G-Coviella IL, Wurtman RJ. Enhancement by cytidine of membrane phospholipid synthesis. J Neurochem 1992; 59: 338-343.
15. Millington WR, Wurtman RJ. Choline administration elevates brain phosphorylcholine concentrations. J Neurochem 1982; 38: 1748-1752.
16. Ulus IH, Watkins CJ, Cansev M, Wurtman RJ. Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or release. Cell Mol Neurobiol 2006; 26: 563-577.
17. Wurtman RJ, Regan M, Ulus I, Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 2000; 60: 989-992.
18. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res Rev 2006; 52: 389-397.
19. Schwarz E, Prabakaran S, Whitfield P et al. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 2008; 7: 4266-4277.
20. Green P, Anyakoha N, Yadid G, Gispan-Herman I, Nicolaou A. Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 213-220.
21. Yildiz A, Sachs GS, Dorer DJ, Renshaw PF. 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis. Psychiatry Res 2001; 106: 181-191.
22. Kato T, Takahashi S, Shioiri T, Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1992; 26: 223-230.
23. Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry 1995; 152: 915-918.
24. Kato T, Takahashi S, Shioiri T, Inubushi T. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 1993; 27: 53-59.
25. Carlezon WA Jr, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 2005; 57: 343-350.
26. Repligen Corp. RG2417: Targeting a novel mechanism to treat bipolar depression. Last accessed 18 November 2010.
27. Epperson CN, Gueorguieva R, Czarkowski KA et al. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology 2006; 186: 425-433.
28. Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF. Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2009; 34: 1810-1818.
29. Ponder SL, Twieg DB. A novel sampling method for 31P spectroscopic imaging with improved sensitivity, resolution, and sidelobe suppression. J Magn Reson B 1994; 104: 85-88.
30. Jensen JE, Drost DJ, Menon RS, Williamson PC. In vivo brain (31)P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR Biomed 2002; 15: 338-347.
31. Mages F, Rey C, Fonlupt P, Pacheco H. Kinetic and biochemical properties of CTP:choline-phosphate cytidylyltransferase from the rat brain. Eur J Biochem 1988; 178: 367-372.
32. Gimenez R, Soler S, Aguilar J. Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats. Neurosci Lett 1999; 273: 163-166.
33. Vance DE. Boehringer Mannheim Award lecture Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly. Biochem Cell Biol 1990; 68: 1151-1165.
34. Jamil H, Utal AK, Vance DE. Evidence that cyclic AMP-induced inhibition of phosphatidylcholine biosynthesis is caused by a decrease in cellular diacylglycerol levels in cultured rat hepatocytes. J Biol Chem 1992; 267: 1752-1760.
35. Baburina I, Jackowski S. Cellular responses to excess phospholipid. J Biol Chem 1999; 274: 9400-9408.
36. Silveri MM, Dikan J, Ross AJ et al. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed 2008; 21: 1066-1075.
37. Babb SM, Wald LL, Cohen BM et al. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology 2002; 161: 248-254.
38. Jensen JE, Daniels M, Haws C et al. Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Exp Clin Psychopharmacol 2008; 16: 199-206.
39. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005; 10: 900-919.
40. Chapman HA, Bernier D, Rusak B. MRI-related anxiety levels change within and between repeated scanning sessions. Psychiatry Res 2010; 182: 160-164.
41. Schmidt ME, Ernst M, Matochik JA et al. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions. J Nucl Med 1996; 37: 1142-1149.
42. Wang L, Pooler AM, Albrecht MA, Wurtman RJ. Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J Mol Neurosci 2005; 27: 137-145.